Share
 
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
13:00
THPDE0201
Modelling the cost-per-HIV infection averted by couples' voluntary HIV counselling and testing in six African countries
Kristin Wall, Emory University, United States
Abstract
Slides
13:05
THPDE0202
HIV prevention costs and its determinants: evidence from the ORPHEA project in Kenya
Omar Galarraga, Brown University, United States
Abstract
13:10
THPDE0203
Answering the financial question with country programs: what is the cost and impact of adopting the 2015 WHO paediatric HIV treatment guidelines?
Aude Wilhelm, Clinton Health Access Initiative, United Kingdom
Abstract
Slides
13:15
THPDE0204
Average costs of voluntary medical male circumcision and their determinants in Kenya, Rwanda, South Africa and Zambia
Omar Galarraga, Brown University, United States
Abstract
13:20
THPDE0205
Spending more to spend less: the unit costs of a tailored demand creation intervention to increase uptake of voluntary medical male circumcision
Sergio Torres-Rueda, London School of Hygiene & Tropical Medicine, United Kingdom
Abstract

13:25
THPDE0206
Rapidly falling costs for new hepatitis C direct-acting antivirals (DAAs): potential for universal access
Dzintars Gotham, Imperial College London, United Kingdom
Abstract
Slides
13:30
THPDE0207
Moderated discussion